By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Avexa Limited 

Victoria      Australia
Phone: 61-3-9208-4000 Fax: 61-3-9208-4356


Company News
PharmaVentures Ltd Engaged by Avexa Limited (AVX:AU) to Assist in the Out-licensing of Apricitabine 7/12/2011 10:36:14 AM
Avexa Limited (AVX:AU) Plunges 75% After Scrapping Most Advanced Drug; Company Announces CEO Resignation, Headcount Reduction and Plan to Explore Strategic Alternatives 5/10/2010 11:41:53 AM
Avexa Limited (AVX.AX) Closes ATC’s Phase III Trial to Evaluate Data 10/2/2009 8:32:58 AM
CSIRO Invests A $2 Million in Avexa Limited (AVX.AX)'s HCV Program 7/15/2009 6:54:09 AM
Avexa Limited (AVX.AX) Announces Changes to Its Board of Directors 7/1/2009 8:49:37 AM
Positive Outcome Reached at 16 Weeks for Avexa Limited (AVX.AX)'s ATC Phase III Trial 6/4/2009 10:17:58 AM
Avexa Limited (AVX.AX) Raises $17M Following Closure of 2009 Rights Issue 4/30/2009 9:15:47 AM
Avexa Limited (AVX.AX) Nominates Proven Pharmaceuticals Executive to Its Board of Directors 4/22/2009 8:47:50 AM
Avexa Limited (AVX.AX) Reaches First Critical Evaluation Point for ATC's Phase III Trial 3/25/2009 9:20:47 AM
Avexa Limited (AVX.AX) Reports Positive 96 Week Data for HIV Drug Apricitabine (ATC) 3/16/2009 7:21:51 AM